Browsing Caprisa (Centre for the Aids programme of research in South Africa) by Advisor "Fiscus, Susan A."

Now showing items 1-3 of 3

Benefits and risks of antiretroviral therapy for perinatal HIV prevention.

Fowler, Mary G.; Qin, Min.; Fiscus, Susan A.; Currier, Judith S.; Flynn, Patricia M.; Chipato, Tsungai.; McIntyre, James.; Gnanashanmugam, Devasena.; Siberry, George K.; Coletti, Anne S.; Taha, Taha E.; Klingman, Karin L.; Martinson, Francis E.; Owor, Maxensia.; Violari, Avy.; Moodley, Dhayendre.; Theron, Gerhard.; Bhosale, Ramesh.; Bobat, Raziya Ahmed.; Chi, Benjamin H.; Strehlau, Renate.; Mlay, Pendo.; Loftis, Amy J.; Browning, Renee.; Fenton, Terence.; Purdue, Lynette.; Basar, Michael.; Shapiro, David E.; Mofenson, Lynne M. (Massachusetts Medical Society., 2016)

Abstract available in pdf.
Comparison of viral env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.

Ping, Li-Hua.; Joseph, Sarah B.; Anderson, Jeffrey A.; Abrahams, Melissa-Rose.; Salazar-Gonzalez, Jesus F.; Kincer, Laura P.; Treurnicht, Florette K.; Arney, Leslie.; Ojeda, Suany.; Zhang, Ming.; Keys, Jessica.; Potter, E. Lake.; Chu, Haitao.; Moore, Penny L.; Salazar-Gonzalez, Maria.; Iyer, Shilpa.; Jabara, Cassandra.; Kirchherr, Jennifer.; Mapanje, Clement.; Ngandu, Nobubelo K.; Seoighe, Cathal.; Hoffman, Irving F.; Gao, Feng.; Tang, Yuyang.; Labranche, Celia.; Lee, Benhur.; Saville, Andrew.; Vermeulen, Marion.; Fiscus, Susan A.; Morris, Lynn.; Abdool Karim, Salim Safurdeen.; Haynes, Barton F.; Shaw, George M.; Korber, Bette T.; Hahn, Beatrice H.; Cohen, Myron.; Montefiori, David C.; Williamson, Carolyn.; Swanstrom, Ronald. (American Society for Microbiology., 2013)

Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effective prevention strategies, including a vaccine.We compared phenotypic and genetic variation in HIV-1 env genes from ...
Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open label, clinical trial.

Flynn, Patricia M.; Taha, Taha E.; Cababasay, Mae.; Fowler, Mary Glenn.; Mofenson, Lynne M.; Owor, Maxensia.; Fiscus, Susan A.; Stranix-Chibanda, Lynda.; Coutsoudis, Anna.; Gnanashanmugam, Devasena.; Chakhtoura, Nahida.; McCarthy, Katie.; Mukuzunga, Cornelius.; Makanani, Bonus.; Moodley, Dhayendre.; Nematadzira, Teacler.; Kusakara, Bangini.; Patil, Sandesh.; Vhembo, Tichaona.; Bobat, Raziya Ahmed.; Mmbaga, Blandina T.; Masenya, Maysseb.; Nyati, Mandisa M.; Theron, Gerhard.; Mulenga, Helen.; Butler, Kevin.; Shapiro, David E. (Wolters Kluwer., 2018)

Abstract available in pdf.

Browsing Caprisa (Centre for the Aids programme of research in South Africa) by Advisor "Fiscus, Susan A."

Benefits and risks of antiretroviral therapy for perinatal HIV prevention. ﻿

Comparison of viral env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design. ﻿

Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open label, clinical trial. ﻿

Benefits and risks of antiretroviral therapy for perinatal HIV prevention.

Comparison of viral env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.

Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open label, clinical trial.